These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16884144)

  • 1. Surveillance and screening of Barrett's oesophagus.
    Lao-Sirieix P; Fitzgerald R
    Br J Hosp Med (Lond); 2006 Jul; 67(7):355-9. PubMed ID: 16884144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surveillance for Barrett's oesophagus: worthwhile?].
    Kastelein F; Kuipers EJ
    Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A surveillance programme for Barrett's oesophagus in a UK general hospital.
    Olithselvan A; Gorard DA; McIntyre AS
    Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
    Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
    Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's esophagus-emerging concepts and controversies.
    Schuchert MJ; Luketich JD
    J Surg Oncol; 2007 Mar; 95(3):185-9. PubMed ID: 17323330
    [No Abstract]   [Full Text] [Related]  

  • 6. Are screening and surveillance for Barrett's oesophagus really worthwhile?
    Sharma P; Sidorenko EI
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i27-32. PubMed ID: 15711005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Barrett's carcinoma of the esophagus.
    Hölscher AH; Vallböhmer D; Bollschweiler E
    Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):347-54. PubMed ID: 19131920
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic approaches to Barrett's oesophagus with high-grade dysplasia/early mucosal cancer.
    Ginsberg GG
    Best Pract Res Clin Gastroenterol; 2008; 22(4):751-72. PubMed ID: 18656828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening and surveillance for Barrett's esophagus-an unresolved dilemma.
    Spechler SJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Sep; 4(9):470-1. PubMed ID: 17609649
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening and surveillance of Barrett's esophagus.
    Regula J
    Dig Dis; 2009; 27(1):54-7. PubMed ID: 19439961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of high-grade dysplasia in patients with Barrett's esophagus.
    Montgomery E; Canto MI
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1434-9. PubMed ID: 17162237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
    Quera R; O'Sullivan K; Quigley EM
    Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt.
    Jamieson GG
    Ann Surg; 2007 Jul; 246(1):22-3. PubMed ID: 17592285
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effectiveness of detecting Barrett's cancer.
    Wright TA; Gray MR; Morris AI; Gilmore IT; Ellis A; Smart HL; Myskow M; Nash J; Donnelly RJ; Kingsnorth AN
    Gut; 1996 Oct; 39(4):574-9. PubMed ID: 8944568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.